Clinical Trial Update: A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging [Phase 4]

View source ↗

Summary

Phase 4 trial of Selexipag in pulmonary arterial hypertension was terminated; results were posted, assessing right ventricular remodeling via cardiac magnetic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Selexipag (selexipag)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2024-08-20